Expression profiling analysis of the CD5+ diffuse large B-cell lymphoma subgroup: Development of a CD5 signature

Cancer Science

Volumn 97, Issue 9, 2006, Pages 868-874

  Suguro, Miyuki ^a,b,c   Tagawa, Hiroyuki ^a   Kagami, Yoshitoyo ^a   Okamoto, Masataka ^d   Ohshima, Koichi ^e   Shiku, Hiroshi ^c   Morishima, Yasuo ^a   Nakamura, Shigeo ^f   Seto, Masao ^a  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

^b Koto ku   (Japan)

^c MIE UNIVERSITY   (Japan)

^d FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e FUKUOKA UNIVERSITY   (Japan)

^f NAGOYA UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CD5 ANTIGEN; CYCLOPHOSPHAMIDE; DOXORUBICIN; GELATINASE B; MESSENGER RNA; OSTEONECTIN; PREDNISOLONE; SCLEROPROTEIN; VINCRISTINE;

ADULT; ARTICLE; B CELL LYMPHOMA; BIOTECHNOLOGY; CLINICAL ARTICLE; CLUSTER ANALYSIS; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MICROARRAY ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; UPREGULATION;

ANTIGENS, CD5; CLUSTER ANALYSIS; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; LYMPHOMA, B-CELL; LYMPHOMA, LARGE-CELL, DIFFUSE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 33746647102     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2006.00267.x     Document Type: Article

References (18)

1. Gatter KC, Warnke RA. Diffuse large B-cell lymphoma. In: Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. World Health Classification of Tumors. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Washington: IARC Press, 2001; 171-4.
2. + groups may constitute clinically relevant subtypes. Leukemia 1999; 13: 1441-7.
3. + diffuse large B-cell lymphoma: A clinicopathologic study of 109 patients. Blood 2002; 99: 815-21.
4. Karnan S, Tagawa H, Suzuki R et al. Analysis of chromosomal imbalances in de novo CD5-positive diffuse large-B-cell lymphoma detected by comparative genomic hybridization. Genes Chromosomes Cancer 2004; 39: 77-81.
5. Tagawa H, Tsuzuki S, Suzuki R et al. Genome-wide array-based comparative genomic hybridization of diffuse large B-cell lymphoma: Comparison between CD5-positive and CD5-negative cases. Cancer Res 2004; 64: 5948-55.
6. Tagawa H, Suguro M, Tsuzuki S et al. Comparison of genome profiles for identification of distinct subgroups of diffuse large B-cell lymphoma. Blood 2005; 106: 1770-7.
7. Alizadeh AA, Eisen MB, Davis RE et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000; 403: 503-11.
8. Rosenwald A, Wright G, Chan WC et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med 2002; 346: 1937-47.
9. Shipp MA, Ross KN, Tamayo P et al. Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning. Nat Med 2002; 8: 68-74.
10. Monti S, Savage KJ, Kutok JL et al. Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response. Blood 2005; 105: 1851-61.
11. Seto M, Yamamoto K, Iida S et al. Gene rearrangement and overexpression of PRAD1 in lymphoid malignancy with +(11;14)(q13; q32) translocation. Oncogene 1992; 7: 1401-6.
12. Eisen MB, Spellman PT, Brown PO, Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 1998; 95: 14863-8.
13. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. A predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med 1993; 329: 987-94.
14. Wright G, Tan B, Rosenwald A et al. A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma. Proc Natl Acad Sci USA 2003; 100: 9991-6.
15. The World Health Organization classification of malignant lymphomas in Japan: Incidence of recently recognized entities. Lymphoma Study Group of Japanese Pathologists. Pathol Int 2000; 50: 696-702.
16. Tamura K, Sawada H, Izumi Y et al. Chronic lymphocytic leukemia (CLL) is rare, but the proportion of T-CLL is high in Japan. Eur J Haematol 2001; 67: 152-7.
17. + diffuse large B-cell lymphoma (LLMPP Study): a distinct entity? Blood 2003; 102: 178a.
18. - diffuse large B-cell lymphomas. Cancer Res 2003; 63: 60-6.